Reduced plasma calcitonin gene-related peptide level identified in cluster headache: A prospective and controlled study
Open Access
- 4 March 2024
- journal article
- research article
- Published by SAGE Publications in Cephalalgia
- Vol. 44 (3)
Abstract
Background: The role of calcitonin gene-related peptide (CGRP) in the cyclic pattern of cluster headache is unclear. To acquire biological insight and to comprehend why only episodic cluster headache responds to CGRP monoclonal antibodies, we examined whether plasma CGRP changes between disease states (i.e. bout, remission and chronic) and controls. Methods: The present study is a prospective case–control study. Participants with episodic cluster headache were sampled twice (bout and remission). Participants with chronic cluster headache and controls were sampled once. CGRP concentrations were measured in plasma with a validated radioimmunoassay. Results: Plasma was collected from 201 participants diagnosed with cluster headache according to the International Classification of Headache Disorders, 3rd edition, and from 100 age- and sex-matched controls. Overall, plasma CGRP levels were significantly lower in participants with cluster headache compared to controls ( p < 0.05). In episodic cluster headache, CGRP levels were higher in bout than in remission (mean difference: 17.1 pmol/L, 95% confidence interval = 9.8–24.3, p < 0.0001). CGRP levels in bout were not different from chronic cluster headache ( p = 0.266). Conclusions: Plasma CGRP is unsuitable as a diagnostic biomarker of cluster headache or its disease states. The identified reduced CGRP levels suggest that CGRPs role in cluster headache is highly complex and future investigations are needed into the modulation of CGRP and its receptors.Keywords
Funding Information
- Research Foundation of the Capital Region of Denmark
- TrygFonden
This publication has 28 references indexed in Scilit:
- Serum Alpha and Beta‐CGRP Levels in Chronic Migraine Patients Before and After Monoclonal Antibodies Against CGRP or its ReceptorAnnals of Neurology, 2023
- Identifying interactions in omics data for clinical biomarker discovery using symbolic regressionBioinformatics, 2022
- Schwann cell endosome CGRP signals elicit periorbital mechanical allodynia in miceNature Communications, 2022
- Trial of Galcanezumab in Prevention of Episodic Cluster HeadacheNew England Journal of Medicine, 2019
- Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache AttacksJAMA Neurology, 2018
- No increase of calcitonin gene–related peptide in jugular blood during migraineAnnals of Neurology, 2005
- Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attackPain, 1995
- Circulating concentrations of calcitonin gene-related peptide (CGRP) in normal man determined with a new, highly sensitive radioimmunoassayPeptides, 1991
- Sensory Neuropeptides (Substance P, Calcitonin Gene-Related Peptide) and Vasoactive Intestinal Polypeptide in Human Saliva: Their Pattern in Migraine and Cluster HeadacheCephalalgia, 1990
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978